爱斯坦·巴尔病毒:癌症中的细胞劫持者
Moyed Alsaadawe1, Bakeel A Radman2, Jingyi Long3
1Department of Laboratory Medicine, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China; Al-Qadisiyah Education Directorate, Ministry of Education, Al-Qadisiyah, Iraq.
Biochimica et biophysica acta. Reviews on cancer
|November 16, 2024
概括
爱斯坦-巴尔病毒 (EBV) 通过破坏细胞生长来驱动淋巴瘤和胃癌等癌症. 目前正在进行的研究重点是疫苗和向治疗,以对抗这些与EBV相关的恶性瘤.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 是一种常见的马疹病毒,感染了全球90%以上的成年人.
- 在B细胞,上皮细胞和NK/T细胞中建立终身潜伏感染.
- 该病毒与各种癌症有关,包括伯基特淋巴瘤,鼻癌,霍奇金淋巴瘤和EBV相关的胃癌.
研究的目的:
- 审查EBV在瘤发生中的作用.
- 突出诊断潜在EBV感染和开发向治疗的挑战.
- 总结目前对抗EBV相关恶性瘤的研究方向.
主要方法:
- 对EBV和癌症研究的文献综述.
- 分析EBV在癌症发展中的分子机制,包括潜伏蛋白 (EBNA-1,LMP1,LMP2A).
- 检查EBV在瘤进展和免疫逃避中的作用.
主要成果:
- 通过抑制细胞灭亡并通过潜伏蛋白促进细胞增殖,EBV有助于癌症.
- 在潜伏和溶解阶段之间EBV的切换加速瘤的进展,特别是在鼻癌.
- 在检测潜伏的EBV感染和开发有效的向治疗方面仍然存在困难.
结论:
- 进一步研究EBV与免疫逃避和癌症形成的相互作用至关重要.
- 疫苗的开发,改进的诊断和向治疗是管理EBV相关癌症的关键.
- 需要加强理解和治疗策略,以减少EBV相关恶性瘤的全球负担.
相关概念视频
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K


